Navigation Links
Prostate tumour growth suppressed by flavonoids

Flavonoids have been regarded as nutritionally good compounds. Lot of research is being done in this direction.//

Apigenin, a flavonoid found in herbs, fruits, and vegetables, slowed the growth of prostate cancer in mice, according to a new study.

Previous studies already found flavonoids (found in fruits and vegetables) had a potential to protect against a number of cancers.

The current study was intended to investigate the preventive and therapeutic effects of apigenin on prostate cancer.

In the study, apigenin was fed to two groups of mice. For one group, the feeding of apigenin started two weeks before prostate cancer was implanted in the mice. For another group, apigenin was fed two weeks after the prostate cancer was implanted.

In both groups, researchers observed that apigenin slowed the growth of prostate cancer, indicating that apigenin possesses both preventive and therapeutic effects on prostate cancer.

Better yet, apigenin did not show any adverse effects such as weight change, which is common in cancer patients who receive chemotherapy.

The researchers did not understand the mechanism for the anticancer properties. They did find that apigenin decreased the levels of IGF-1 or insulin-like growth factor, which had been associated with a higher risk of breast, prostate, colorectal and lung cancers. This indicated that apigenin may have an effect on these cancers as well.

In addition, the researchers found apigenin significantly increased levels of IGFBP-3 (insulin-like growth factor binding protein), which had been associated with a decreased risk of the same cancers.

Apigenin induced cancer cell death, according to the study. Previous studies revealed apigenin reduces inflammation and oxidative stress, which inhibits the growth of cancer cells.

Apigenin is found in a range of fruits and vegetables including apples, beans, broccoli, cherries, grapes, leeks, onions, pa rsley, celery and tomatoes. Apigenin is also found in tea and wine.

Dr Sanjay Gupta and colleagues at Case Western Reserve University conducted the research study.

(Federation of American Societies for Experimental Biology journal)
'"/>




Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
3. New Prostate Cancer Vaccine Shows Promise
4. Hormone Therapy applicable for Prostate Cancer
5. Prostate cancer and Vitamins
6. Response to chemotherapy could be measured by Prostate-Specific Antigen Doubling Time
7. Early Detection Of Prostate Cancer
8. Awareness increase Prostate cancer detection
9. Better Prostate Cancer Test
10. Stopping Prostate Cancer from Spreading
11. Drug might prevent Prostate Cancer Spread
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/5/2016)... ... ... Will Never Be The Same” is a fictional tale about growing up with the ... the creation of published author, Kim T. Briggs, a self-described “big kid” who has ... and philosophy from Judson University in Elgin, Illinois. Having written numerous Christian drama skits ...
(Date:12/5/2016)... (PRWEB) , ... December 05, 2016 , ... ... ability of physical therapist assistants, under direct supervision of a licensed physical therapist, ... physical therapy receives a consultation and treatment plan from a licensed physical therapist ...
(Date:12/5/2016)... IL (PRWEB) , ... December 05, 2016 , ... The ... to the individual looking to buy neoprene knee sleeves for lifting and ... The design focuses heavily on two main aspects to provide a higher quality knee ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... an excellent way to ensure moisture measurements are consistently correct. However, regular ... , Now, METTLER TOLEDO offers a solution: SmartCal™ . This ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... they have teamed up with The American College of Surgeons (ACS) to provide ... on Trauma, the “Bleeding Control Basic” course is a pilot program that fulfills ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... PARSIPPANY, N.J. , Dec. 5, 2016 ... today announced preliminary safety and efficacy data from ... oral selective MDM2 inhibitor, suggesting that DS-3032 may ... relapsed/refractory acute myeloid leukemia (AML) and high-risk myelodysplastic ... part of the phase 1 study of DS-3032 were ...
(Date:12/5/2016)... , Dec. 5, 2016 Eisai Inc. announced ... the 2016 Annual Meeting of the American Epilepsy Society ... is indicated as an adjunctive therapy for the treatment ... generalized seizures and primary generalized tonic-clonic seizures (PGTC) in ... and older. Please see Important Safety Information for FYCOMPA, ...
(Date:12/5/2016)... BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage ... candidates, presents positive Phase 2a correlative data, as well as ... at the ongoing 58th American Society of Hematology (ASH) Annual ... . ... As previously announced, in ...
Breaking Medicine Technology: